J. Biol. Chem., Vol. 261, Issue 15, 6772-6777, May, 1986
3-Methylene-substituted androgens as novel aromatization inhibitors. Evidence of a requirement for C-3 oxygen in C-19 hydroxylations
S Miyairi and J Fishman
Substitution of a methylene group for the C-3 oxygen in androstenedione,
testosterone, and the corresponding 19-hydroxy and 19- oxo derivatives
results in a new category of inhibitors of estrogen biosynthesis by human
placental microsomes. The inhibition is of the competitive type with the
most effective inhibitors being the 17- ketonic compounds,
3-methyleneandrost-4-en-17-one, 19-hydroxy-3- methyleneandrost-4-en-17-one,
and 3-methylene-19-oxoandrost-4-en-17-one with apparent Ki values of 4.7,
13, and 24 nM, respectively. The 3- methylene derivatives of
androstenedione and 19-hydroxyandrostenedione were effective substrates for
the placental microsomal 17 beta-hydroxy- steroid oxidoreductase but were
only marginally hydroxylated at the C- 19 position to the respective
19-hydroxy and 19-oxo derivatives. The 3- methylene analogs are thus
competitive inhibitors of aromatization but are not substrates for this
enzyme complex. Time-dependent inhibition of aromatization by 10
beta-difluoromethylestr-4-ene-3,17-dione and 10
beta-(2-propynyl)estr-4-ene,3,17-dione was abolished by substitution of a
methylene function for the C-3 oxygen, suggesting that the presence of an
oxygen at C-3 is required for an oxidative transformation at C- 19, an
initial step in aromatization. The essential role of the C-19 hydroxylation
in aromatization is supported by the observation that the 3-methylene
derivatives of 19-hydroxy- and 19-oxoandrostenedione showed time-dependent
inhibition, but the corresponding 19-methyl compound did not. The
3-methylene androgens are potent inhibitors of placental aromatization but
are themselves only marginal substrates for the enzyme. Their high affinity
for and inertness to the placental aromatase complex makes them valuable
probes of the aromatization process.